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Abstract
Background: Parkinson’s disease (PD) represents a major public health challenge that will only grow in our aging population. Understanding the connection
between PD and associated prodromal conditions, such as rapid eye movement sleep behavioral disorder (RBD), is critical to identifying prevention strategies.
However, the relationship between RBD and severity of motor findings in early PD is unknown. This study aims to examine this relationship.
Methods: The study population consisted of 418 PD patients who completed the Movement Disorders Society-United Parkinson’s Disease Rating Scale (MDS-
UPDRS) and rapid eye movement sleep (REM) disorder questionnaires at the baseline visit of the Michael J. Fox’s Parkinson’s Progression Markers Initiative
(PPMI). Cross-sectional analysis was carried out to assess the association between REM Sleep Behavior Screening Questionnaire score and MDS UPDRS-3 (motor)
score categories. Correlation with a higher score category was described as ‘‘worse motor findings’’. A score of 5 on the REM disorder questionnaire was defined as
predictive of RBD.
Results: Out of the 418 PD patients, 113 (27.0%) had RBD. With univariate logistic regression analysis, individuals with scores predictive of RBD were 1.66 times
more likely to have worse motor findings (p50.028). Even with age, gender, and Geriatric Depression Scale scores taken into account, individuals with scores
predictive of RBD were 1.69 times more likely to have worse motor findings (p50.025).
Discussion: PD patients with RBD symptoms had worse motor findings than those unlikely to have RBD. This association provides further evidence for the
relationship between RBD and PD.
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Introduction
As medical advances extend human life, the prevalence of age-related
diseases, including Parkinson’s disease (PD) will increase worldwide.1
Motor disability has been considered the hallmark of PD and a standard
measure of disease severity, particularly when no PD medications
confound the rating. Mobility and motor findings are an important
determinant of PD patients’ functionality and therefore highly relevant
to their health status.2 Symptomatic therapies are readily available for
PD with overall excellent results, yet they fail to prevent or delay disease
progression and are limited in improving patients’ quality of life in late
stages of the disease. With only preventative or disease-modifying
therapies offering the prospect of a profound and lasting impact on PD
patients’ lives, interventions aimed at the disease process and applied
before the motor findings manifest are extremely appealing.
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Prodromal manifestations predate the appearance of motor
symptoms often by years. Specifically, there is now direct evidence
that certain prodromal symptoms, such as anosmia, rapid eye
movement (REM) sleep behavior disorder (RBD), constipation, and
depression can be present in the prodromal phase of PD.3
Understanding the connection between PD and prodromal conditions,
such as RBD, is critical to research efforts aimed at prevention and
disease modification.
RBD is a parasomnia manifested by vivid, often frightening dreams
associated with simple or complex motor behavior during REM sleep.4
Fulda et al.5 reported that RBD may be one of the earliest signs of
and/or a long-term predictor for neurodegenerative disorders,
particularly PD.5 RBD and stage 2 of PD (i.e., the stage of disease
when PD symptoms are bilateral, affecting both limbs and both sides of
the body), both show pathomorphological similarity by way of
demonstration of alpha-synuclein pathology in the brain, suggesting
that RBD is a pathway to PD.5 In fact, patients with RBD have up to a
65% risk of developing PD at 10 years, making RBD a specific clinical
marker of premotor PD.6 RBD has been reported to be present in
42.6% of all PD patients.7 Despite these high percentages, only a few
systematic, large-scale studies have investigated the characteristics of
RBD in PD. The Parkinson’s Progression Marker Initiative (PPMI) is
one such effort which encompasses 32 internationally recognized
clinical sites that are jointly involved in a comprehensive study
designed to identify potential PD progression biomarkers.8 The PPMI
therefore provides an early opportunity to examine relationships
between motor findings and factors which could potentially influence
them at the onset of PD in a large, untreated, imaging-confirmed
cohort of newly diagnosed PD patients.
Although several studies have examined RBD as a potential
prodromal condition for PD,6 our analysis specifically seeks to assess
the association between RBD and early-onset PD motor findings
severity.
In this analysis, we aim to evaluate the independent association
between RBD and motor findings in PD, accounting for age, gender,
and common comorbid PD conditions such as depression. The PPMI
study presents a unique opportunity to examine such associations in
patients that are newly diagnosed, where medications do not confound
motor measures. The presence of an independent association between
RBD and motor finding severity in early disease may help further
establish the link between prodromal states and classical motor
manifestations of PD. Such findings could help advance the under-
standing of PD’s prodromal states, which may lead to preventative
therapies.
Methods
The PPMI study includes a cohort of PD patients and healthy
participants enrolled for clinical assessments, imaging data, and bio-
specimen collection using standardized data acquisition protocols.8
The uniqueness of PPMI lies in the fact that it is the largest de novo PD
cohort in history. It includes PD patients whose symptoms do not
require medications for motor symptoms at the time of enrollment and
up to 6 months thereafter (per enrolling investigator’s judgment).
Furthermore, each of the PPMI cohort’s PD patients underwent
nuclear imaging to confirm striatal dopamine deficit.8 The majority of
the patients had DaTscan, which uses ioflupane iodine-123 as a tracer
with single-photon emission computed tomography for measuring the
dopamine transporter. Australian sites used AV-133, a positron
emission tomography tracer [9-[(18) F]fluoropropyl-(+)-dihydrotetra-
benazine ([(18)F]AV-133)]. An abnormal scan (either DaTscan or AV-
133) was an inclusion criterion for the patient group. The Johns
Hopkins Medicine Institutional Review Board approved the PPMI
study at our site. The data are publically accessible through a standard
application process using the PPMI website. Our team was granted
such access by the PPMI Data and Publications Committee (DPC).
Additionally, our manuscript was submitted to the PPMI DPC and
received administrative approval.
A total of 418 participants with complete data on the selected
variables were included in this analysis. We present an abbreviated
version of the study participant enrollment criteria as it relates to the
current data extraction. Please refer to previously published papers for
in-depth descriptions of the overarching PPMI longitudinal study
methods as well as the inclusion and exclusion criteria.8 Data used for
this analysis were obtained from the PPMI database (version 08-01-
2013).9
The demographics of all study participants were collected at the
screening visit. Once enrolled, the participants underwent a series of
tests including the Movement Disorders Society-United Parkinson’s
Disease Rating Scale (MDS-UPDRS) and REM Sleep Behavior
Questionnaire. MDS-UPDRS testing was administered by a certified
movement disorders expert.
The RBD questionnaire is a validated 10-item patient self-rating
questionnaire covering the clinical features of RBD. With a maximum
total score of 13 points, a cut-off of 5 is considered suggestive of
RBD.10 While this measure cannot make the diagnosis of RBD or
substitute polysomnography, it was deemed appropriate for the
purposes of evaluating a possible association between RBD symptoms
and motor manifestations.
For the Geriatric Depression Scale (GDS), a cut-off of 5 was
considered suggestive of depression.11 We included scores of MDS-
UPDRS 3 (motor) questionnaire in this study. The MDS-UPDRS
scale is a Movement Disorders Society (MDS)-sponsored revision of
the widely used UPDRS scale. The original UPDRS placed
considerable emphasis on marked and severe disabilities or impair-
ments. The MDS-UPDRS scale may be better tuned for mild
impairment.12 For the MDS-UPDRS 3 (motor) section of the MDS-
UPDRS scale, the total score is 120. MDS-UPDRS scores are not
linear. In a study evaluating biomarkers of PD, Lin et al.13 used a
method of grouping UPDRS scores to classify PD severity into
categories. For the purpose of clinical significance and applicability, we
devised four categories for the severity of motor findings:
N Category MDS-UPDRS III score range
N Very mild: 0–5
N Mild: 6–24
Mahajan A, Rosenthal LS, Gamaldo C, et al. RBD Symptomatology and Motor Findings in Parkinson’s Disease
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services2
N Moderate: 25–60
N Severe: .60
Finally, an ordered logistic regression model was constructed with
age, gender, REM sleep score category, and GDS score category as
predictor variables. The outcome variable was MDS-UPDRS III
scores, which were categorized as above.
Statistical analysis
Statistical procedures were performed with STATA, Version SE 12
for Windows (College Station, TX). Significance was set a priori at
p,0.05. A two-sided t test was conducted to evaluate the strength of
correlation between dependent and independent variables. The
outcome variable, MDS-UPDRS III score, was classified into four
categories of motor severity (very mild, mild, moderate, and severe). As
the outcome variable is ordinal in nature, a likelihood ratio test for
proportionality of odds across response categories was conducted and
the parallel regression assumption was not found to be violated
(prob.chi2: 0.4119). Ordered logistic regression models, in univariate
and multivariate forms were used to investigate the contribution of
individual variables to the prediction of motor findings. Based on the
ordered regression analysis, correlations were made between the
predictor variables and the outcome variable. The correlation of a
higher MDS-UPDRS III category with RBD symptomatology was
described as ‘‘worse motor findings’’ with RBD symptomatology.
The RBD screening questionnaire score was treated as a binary
variable. Participants with a score above 5 were classified as having
RBD symptomatology.10
Results
A total of 418 participants with data on RBD questionnaire scores,
GDS scores, MDS-UPDRS 3 scores, and demographic variables were
analyzed. In this group, 122 (29.2%) were women and 272 (65.1%)
were men. The data on gender of 24 participants were missing. The
average age of participants was 62.9 years, ranging from 34 years to 86
years of age (Table 1).
For the sake of simplicity, we refer to our arbitrarily defined group
with the higher RBD questionnaire score (.5) as ‘‘likely RBD’’,
whereas those with low score (#5) on the questionnaire as ‘‘unlikely
RBD’’. Of the 418 PD patients included in this analysis, 113 (27%)
were classified as PD patients with likely RBD, while 305 (72.9%) were
classified as unlikely RBD.
Two individuals (0.5%) were classified with very mild motor findings
such as minimal to no bradykinesia, rigidity, postural instability,
freezing of gait, resting tremors, etc., 290 (69.4%) with mild severity of
motor findings, and 126 (30.1%) patients with moderate severity of
motor findings. There were no participants who were classified with
severe motor findings.
In univariate logistic regression analysis, the odds of having worse
motor findings were 1.66 times in participants with likely RBD
compared with those unlikely to have RBD (p50.028, 95% CI: 1.057–
2.62). Even when age, gender and GDS scores were taken into
account, the association between RBD and MDS-UPDRS 3 score
categories was significant (OR51.69, 95% CI: 1.07–2.69, p50.025).
Among patients unlikely to have RBD, 27.2% have moderate motor
findings and 72.1% have mild motor findings. In patients with likely
RBD, this percentage goes up to 38% for moderate motor findings,
with 61.9% for those with mild motor findings (Figure 1) (p50.025).
A sub-analysis was conducted using just Question 6 (question on
‘‘dream enactment’’) of the REM sleep behavior screening question-
naire as a binary variable (presence 1–4 vs. absence [0]) in place of the
REM sleep behavior disorder screening questionnaire score in the
model. Using Question 6 as a tool for identifying patients with likely
RBD, the odds of having worse motor findings in PD patients with likely
REM sleep behavior disorder are 0.71 times compared to PD patients
unlikely to have REM sleep behavior disorder (p50.115, 95% CI: 1.08–
2.22). After accounting for age, gender, and GDS scores, the odds of
having worse motor findings in PD patients with likely REM sleep
behavior disorder are 1.34 times compared to PD patients unlikely to
have REM sleep behavior disorder (p50.171, 95% CI: 0.488–1.135).
Discussion
Based on the results of this analysis, we report that a RBD
questionnaire score of greater than 5, indicative of RBD symptoms, is
an independent predictor of worse motor findings in PD patients.
Table 1. Characteristics at Baseline of Participants with Likely RBD and Unlikely RBD
Patients with Likely RBD (113) Patients with Unlikely RBD (305) p
Gender (% male) 82 (72.57%) 190 (62.30%) 0.03
Depression
(GDS.5)
47 (33.1%) 91 (66.9%) 0.06
Age 63.04 years (SD: 9.74) 62.87 years (SD: 9.76) 0.85
RBD, Rapid Eye Movement Sleep Behavioral Disorder.
Data on bed partners and usage of antidepressants was not a part of this analysis. RBD screening questionnaire scores and MDS UPDRS III scores were categorized for
the purpose of analysis. Details have been discussed in the manuscript.
This table compares baseline characteristics between patients with likely RBD and patients with unlikely RBD. Our analysis showed a statistically significant difference in
the percentage of males between the two groups. There was no significant difference in the GDS-indicated depression percentage and age between the two groups.
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This is the first study to our knowledge evaluating the relationship
between RBD symptoms and motor severity within a large de novo,
imaging-confirmed PD cohort. We found the odds of having worse
motor findings were 1.66 times greater in patients with likely RBD
than those unlikely to have RBD (p50.028). After age, gender, and
GDS scores were taken into account, the odds of having worse motor
findings were 1.69 times greater in patients with potential RBD than
those likely without RBD (p50.025). Among patients unlikely to have
RBD, 27.2% had moderate motor findings, and this percentage went
up to 38% for patients with RBD (p50.0253) (Figure 1). These data
indicate that PD patients with potential RBD have worse motor
findings than those unlikely to have RBD.
Apart from motor findings, the association between depression and
sleep issues in PD has been well studied and established in the
literature.14 Up to 50% of PD patients suffer from comorbid depression;
a relationship that is associated with increased disability and reduced
quality of life.15 Although RBD has not been shown to be independently
associated with depression in previous studies, we decided on including
depression in our predictor model on the basis of its known association
with sleep and PD.2,14 Our analysis found that even when age, gender,
and depression were taken into account, there is a significant
independent association between RBD and motor severity in PD.
There is robust evidence associating RBD with PD based on
common neurobiological and neuropathological clues. A possible
explanation for an association between REM sleep and PD was given
by Rye and Jankovic in 2002,16 where they hypothesized that with
dopamine playing a complex role in the sleep–wake cycle, some sleep
disturbances in PD might be dopamine sensitive.16 Therefore a larger
or earlier dopamine deficit might predict both the presence of RBD
and greater motor severity. Our findings corroborate that notion.
It has also been suggested that the presence of RBD in PD assumes a
more extensive neurodegenerative process,17 which includes choliner-
gic, serotonergic, and norepinephrine networks. This would be
consistent with the fact that some of these non-dopaminergic networks
are involved with REM sleep.
It has been widely accepted that RBD is a prodromal condition for
PD. An article by Meissner18 on the onset of PD stated that olfactory
disturbances, RBD, and autonomic dysfunction may precede the onset
of motor signs by up to four decades. In a study published in April
2013, Maass and Reichmann19 also reported that RBD might predate
PD. However, association of RBD with motor findings in untreated
PD has not been evaluated sufficiently in the literature.
One of the strengths of our study is that none of the included study
patients were on PD medications at the time their data were captured
for the purposes of this cross-sectional analysis. This enables us to
assess the association between RBD and motor severity in PD whereby
it is not confounded by PD medications.
Disease severity could potentially confound the relationship between
RBD and motor severity in PD. However, the PPMI cohort only
includes patients with less than 2 years of disease duration, making this
cohort relatively homogeneous from the standpoint of disease severity.
Another major advantage of our analysis is dopamine imaging
confirmation of all PD cases. It is correct that some other
dopaminergic neurodegenerative diseases may also produce an
abnormal scan that cannot distinguish between these entities; however,
this technique certainly augments the accuracy of the clinical diagnosis
of PD and therefore enhances the likelihood that other movement
disorders, such as essential tremor, dystonic tremor, and secondary
forms of parkinsonism are excluded.
One of the limitations of the study is that the full range of motor

















Likely - RBD Unlikely - RBD
Variaon of severity of motor findings with 
RBD symptomatology
Very Mild Mild Moderate
Figure 1. Distribution of Severity of Motor Symptoms in Participants with Likely RBD and unlikely RBD. RBD, rapid eye movement sleep behavioral
disorder.
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and the generalizability to more severe stages is questionable.
Longitudinal studies may help further elucidate the association
between motor PD and RBD.
The cohort used for our analysis is missing information on gender in
24 participants (5.74%). We assume that such a small fraction of
randomly missing data on gender should have no bearing on our
analyses. However, we do acknowledge it to be a limitation.
Another potential limitation is that the PPMI cohort could be
slightly skewed toward tremor-predominant cases, and the possible
slight over-representation of tremor-predominant over non-tremor-
predominant cases in this cohort relative to the general PD population
will have to be taken into account. Previous studies have acknowledged
the high prevalence of tremor as the initial symptom in PD patients.20
A preliminary analysis conducted by us on the baseline clinical
characteristics of PPMI study patients shows similar results.
The PPMI study does not have data on the input of bed partners of
the participants. Since the RBD screening questionnaire involves
questions regarding hurting one’s bed partner and dream enactment,
this could be considered a potential limitation of the study.
Other potential limitations of this investigation include relevance
and validity of the tools used for RBD and depression. Our analysis
defines ‘‘likely RBD’’ using the screening cut-off guidelines for the
REM sleep behavior disorder screening questionnaire by Stiasny-
Kolster et. al.10 The cut-off has excellent sensitivity (0.96) but low
specificity (0.56) for patients who present to the clinic. Therefore, while
this gives a fairly good indication of the condition, it primarily serves as
an RBD screening tool and not a diagnostic tool that calls for clinical
history of dream enactment and evidence of REM sleep without atonia
on a polysomnography (which involves a more complex level of
financial and technical resources). However, the REM sleep behavior
screening questionnaire fares better when applied to the general
population, i.e., who were not seen at a sleep center, with a specificity
of 92%.10 There have also been questions regarding using the REM
sleep behavior disorder screening questionnaire in PD patients, since it
has been shown to give high values in healthy controls as well.
However, the RBD questionnaire has also been validated in a cohort
of PD patients by Nomura et al.21
Despite these potential limitations, Question 6 of the REM Sleep
Behavior Questionnaire, ‘‘dream enactment’’ (e.g. evidence of talking/
swearing, sudden limb movements, gestures/complex movements, and
things that fell around the bed) has been shown to be highly sensitive
and specific to REM sleep behavior disorder.22 In their multicenter
study involving 484 sleep clinic-based participants, with polysomno-
graphy as the gold standard, Postuma et al.22 found that the ‘‘dream
enactment’’ question had a sensitivity of 93.8% and a specificity of
87.2% to detect RBD. However, in our sub-analysis, using Question 6
as a tool for classification of RBD, this correlation was not statistically
significant (p50.171, 95% CI: 0.4884–1.135).
To confirm and further evaluate the relationship in future studies,
we recommend employing questionnaires more specific for RBD, like
the Mayo Sleep Questionnaire,23 and confirmatory polysomnography
in participants screened to have RBD by the RBD questionnaire in this
analysis. Additional analysis could be done to further delineate the
relationship between both clinical (i.e., frequency and severity of
dream enactment episodes) as well as polysomnography RBD
characteristics and PD motor signs.
Age, gender, and depression have been previously associated with
motor symptoms in PD.24–26 In our model, we included age, gender,
GDS scores, and REM Sleep Behavior Disorder Questionnaire score as
dependent variables for the outcome, MDS-UPDRS III score categories.
It may be important to include more demographic and other dependent
variables that could potentially affect outcome variables such as
socioeconomic status, educational status, usage of antidepressants,
presence of bed partners, current and past alcohol use, presence of
other chronic and psychiatric disorders, etc., in future analyses.
Our analysis indicates that RBD could be a valuable target for further
studies aimed at interventions to improve motor findings and
functioning in PD patients. Further research aimed at understanding
prodromal symptoms of PD and evaluating their relationship with
motor manifestations will contribute to our understanding of prodromal
pathology and will ultimately help efforts towards prevention.
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